CAMBRIDGE, Mass., Jan. 27, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will report its financial results for the fourth quarter and year ended December 31, 2010 before the U.S. financial markets open on Thursday, February 10, 2011.
